HLA PRE-TRANSPLANT WORKUP PANEL 2 Test
Test Name: HLA PRE-TRANSPLANT WORKUP PANEL 2 Test
Components: HLA-A, HLA-B, HLA-C, HLA-DR, HLA-DQ
Price: 4800.0 AED
Sample Condition: RECIPIENT: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 9 mL (6 mL min.) serum from 3 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND 4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Collect specimen preferably 48 hours after dialysis. Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Report Delivery: 10-12 days
Method: Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry
Test type: Transplantation
Doctor: Nephrologist
Test Department:
Pre Test Information: Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Test Details:
HLA Pre-Transplant Workup Panel 2 test is a blood test that is performed to determine the compatibility between a potential organ donor and recipient. This test is usually done before a kidney transplant, but it can also be done for other types of organ transplants. The test analyzes the Human Leukocyte Antigen (HLA) system, which is a group of proteins found on the surface of white blood cells. These proteins help the immune system identify which cells are part of the body and which are foreign. The HLA Pre-Transplant Workup Panel 2 test looks at a specific set of HLA proteins, including HLA-A, HLA-B, HLA-C, HLA-DR, and HLA-DQ. By comparing the HLA profiles of the donor and recipient, doctors can determine the likelihood of the recipient’s immune system rejecting the transplanted organ. The test involves taking a blood sample from both the donor and recipient and analyzing it in a laboratory. The results are reported as a percentage match between the two individuals, with a higher percentage indicating a better match. Overall, the HLA Pre-Transplant Workup Panel 2 test is an important tool for ensuring the success of organ transplantation and reducing the risk of rejection.
Test Name | HLA PRE-TRANSPLANT WORKUP PANEL 2 Test |
---|---|
Components | |
Price | 4800.0 AED |
Sample Condition | RECIPIENT: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 9 mL (6 mL min.) serum from 3 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND 4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Collect specimen preferably 48 hours after dialysis. Ship at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory. |
Report Delivery | 10-12 days |
Method | Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry |
Test type | Transplantation |
Doctor | Nephrologist |
Test Department: | |
Pre Test Information | Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory. |
Test Details | HLA Pre-Transplant Workup Panel 2 test is a blood test that is performed to determine the compatibility between a potential organ donor and recipient. This test is usually done before a kidney transplant, but it can also be done for other types of organ transplants. The test analyzes the Human Leukocyte Antigen (HLA) system, which is a group of proteins found on the surface of white blood cells. These proteins help the immune system identify which cells are part of the body and which are foreign. The HLA Pre-Transplant Workup Panel 2 test looks at a specific set of HLA proteins, including HLA-A, HLA-B, HLA-C, HLA-DR, and HLA-DQ. By comparing the HLA profiles of the donor and recipient, doctors can determine the likelihood of the recipient’s immune system rejecting the transplanted organ. The test involves taking a blood sample from both the donor and recipient and analyzing it in a laboratory. The results are reported as a percentage match between the two individuals, with a higher percentage indicating a better match. Overall, the HLA Pre-Transplant Workup Panel 2 test is an important tool for ensuring the success of organ transplantation and reducing the risk of rejection. |